GARP:BATS-iShares MSCI USA Quality GARP ETF (USD)

ETF | Others |

Last Closing

USD 57.65

Change

-0.08 (-0.14)%

Market Cap

USD 0.35B

Volume

0.27M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
FBTC Fidelity Wise Origin Bitcoin T..

+1.28 (+1.41%)

USD 20.46B
INDA iShares MSCI India ETF

+0.12 (+0.22%)

USD 8.92B
PAVE Global X U.S. Infrastructure D..

-0.05 (-0.12%)

USD 7.74B
BUFR First Trust Cboe Vest Fund of ..

+0.02 (+0.06%)

USD 6.29B
BOXX Alpha Architect 1-3 Month Box ..

+0.02 (+0.02%)

USD 6.29B
ARKB ARK 21Shares Bitcoin ETF

+1.46 (+1.41%)

USD 4.99B
BBUS JPMorgan BetaBuilders U.S. Equ..

+0.13 (+0.12%)

USD 4.22B
KNG FT Cboe Vest S&P 500® Dividen..

-0.03 (-0.06%)

USD 3.55B
GSUS Goldman Sachs MarketBeta US Eq..

+0.11 (+0.13%)

USD 2.41B
IFRA iShares U.S. Infrastructure ET..

+0.11 (+0.23%)

USD 2.23B

ETFs Containing GARP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.49% 67% D+ 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.49% 67% D+ 64% D
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.35B 86% B+ 79% B-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike